GDP: Questions & Answers about the Scope of the EU-GDP Guidelines
Recommendation
9 September 2025
Basel, Switzerland
Specifics in the Distribution of Medicinal Products
Register now for ECA's GMP Newsletter
The European GDP Association has recently updated its "Good Distribution Practices (GDP) - FAQs". In this second set of questions and answers, details about the scope are addressed. The following ambiguities are clarified:
Do the EU-GDP Guidelines apply for:
- Veterinary products?
- Investigational Medicinal Products (IMPs)?
- Active Pharmaceutical Products (APIs) and Excipients?
- Hubs?
But the issuance of official GDP certificates is also explained. It is pointed out that "transport companies do not need to hold a wholesale distribution authorisation to transport medicinal products". But, of course, they need to "follow the parts of the GDP guideline relevant to their activities, amongst others Chapter 9". EU competent supervisory authorities carry out GDP inspections (and issue GDP certificates) only of companies holding wholesale distribution authorisations or companies which are aiming for one. Some are also part of GMP inspections at pharmaceutical manufacturers.
Find out more in the FAQs on the European GDP Association website.
Related GMP News
10.06.2025Stimuli Article Proposes Revision of USP Definition of Controlled Room Temperature (CRT)
10.06.2025New MHRA Blog Post: Supplying Medicines to Ships, Aircraft and Oil Platforms
10.06.2025Questions and Answers from the ECA Webinar "GDP Update 2025" - Part 3
10.06.2025Meet the GDPA Board Members at the GDP Forum in Barcelona
10.06.2025Swissmedic Technical Interpretation: What Counts as a Major Change in GDP?
10.06.2025MHRA informes about Validity Date of UK issued GDP Certificates